Scenario Planning and Competitive Strategies
BackgroundClient's drug was the first product in its class to receive a new expanded indication. A key competitor, the market leader, was expected to receive approval for the same and additional indications within the year. The client and its co-marketing partner were unsure how the competitor would evolve its strategy given its new breadth of indications.
"You provided tremendous insight. By challenging our assumptions, you helped us better prepare for this threat. The agency we use for competitive monitoring could not have gotten us here."